Cargando…

Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis

PURPOSE: To evaluate 10 years of KAMRA corneal inlay explantation and associated visual outcomes. PATIENTS AND METHODS: Single-site retrospective chart review of 22 cases of AcuFocus KAMRA Inlay (ACI7000PDT) explantation (range 1 week–1 year). Uncorrected distance visual acuity (UDVA), uncorrected n...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshirfar, Majid, Lau, Chap-Kay, Chartrand, Nicholas A, Parsons, Mark T, Stapley, Seth, Bundogji, Nour, Ronquillo, Yasmyne C, Linn, Steven H, Hoopes, Phillip C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553435/
https://www.ncbi.nlm.nih.gov/pubmed/36237487
http://dx.doi.org/10.2147/OPTH.S382544
_version_ 1784806470097829888
author Moshirfar, Majid
Lau, Chap-Kay
Chartrand, Nicholas A
Parsons, Mark T
Stapley, Seth
Bundogji, Nour
Ronquillo, Yasmyne C
Linn, Steven H
Hoopes, Phillip C
author_facet Moshirfar, Majid
Lau, Chap-Kay
Chartrand, Nicholas A
Parsons, Mark T
Stapley, Seth
Bundogji, Nour
Ronquillo, Yasmyne C
Linn, Steven H
Hoopes, Phillip C
author_sort Moshirfar, Majid
collection PubMed
description PURPOSE: To evaluate 10 years of KAMRA corneal inlay explantation and associated visual outcomes. PATIENTS AND METHODS: Single-site retrospective chart review of 22 cases of AcuFocus KAMRA Inlay (ACI7000PDT) explantation (range 1 week–1 year). Uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), corrected distance visual acuity (CDVA), and manifest refraction at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year post-explantation were reviewed. RESULTS: The explantation rate was 8.2% across 10 years. All patients underwent KAMRA explantation due to dissatisfaction with their vision including blurry near vision, impaired night vision, decreased vision in dim lighting, streaks or halos, haze, and double vision. Mean UDVA pre-implant was −0.01±0.13 logMAR (logarithm of the minimal angle of resolution), 0.30±0.22 logMAR pre-explant, and 0.16±0.15 logMAR post-explant (n=20). Mean UNVA pre-implant was 0.37±0.09 logMAR, 0.38±0.13 logMAR pre-explant, and 0.42±0.21 logMAR post-explant (n=20). Mean CDVA pre-implant was −0.01±0.04 logMAR and 0.05±0.11 logMAR post-explant (n=17). Mean CDVA pre-explant was 0.04±0.07 logMAR and 0.04±0.11 logMAR post-explant (n=19). Significant differences were observed between pre-implant and post-explant UDVA (p=0.009), and between pre-explant and post-explant UDVA (p=0.02). All patients (100%) had 20/20 or better CDVA pre-implant but decreased to 73.7% post-explant. Sixty percent (12/20) of the patients lost UDVA Snellen acuity lines post-explant. MRSE was −0.31±0.29 D pre-implant and +0.26±0.77 D post-explant (p=0.007) with note of a hyperopic shift. The hyperopic shift in 31.6% (6/19) of patients did not resolve after explantation. Post-explant residual corneal haze occurred in 72.7% (16/22) of patients. CONCLUSION: Although the KAMRA corneal inlay is a removable device, patients may experience residual corneal haze, hyperopic shift, and deficits in UDVA after explantation compared to pre-implantation UDVA.
format Online
Article
Text
id pubmed-9553435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95534352022-10-12 Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis Moshirfar, Majid Lau, Chap-Kay Chartrand, Nicholas A Parsons, Mark T Stapley, Seth Bundogji, Nour Ronquillo, Yasmyne C Linn, Steven H Hoopes, Phillip C Clin Ophthalmol Original Research PURPOSE: To evaluate 10 years of KAMRA corneal inlay explantation and associated visual outcomes. PATIENTS AND METHODS: Single-site retrospective chart review of 22 cases of AcuFocus KAMRA Inlay (ACI7000PDT) explantation (range 1 week–1 year). Uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), corrected distance visual acuity (CDVA), and manifest refraction at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year post-explantation were reviewed. RESULTS: The explantation rate was 8.2% across 10 years. All patients underwent KAMRA explantation due to dissatisfaction with their vision including blurry near vision, impaired night vision, decreased vision in dim lighting, streaks or halos, haze, and double vision. Mean UDVA pre-implant was −0.01±0.13 logMAR (logarithm of the minimal angle of resolution), 0.30±0.22 logMAR pre-explant, and 0.16±0.15 logMAR post-explant (n=20). Mean UNVA pre-implant was 0.37±0.09 logMAR, 0.38±0.13 logMAR pre-explant, and 0.42±0.21 logMAR post-explant (n=20). Mean CDVA pre-implant was −0.01±0.04 logMAR and 0.05±0.11 logMAR post-explant (n=17). Mean CDVA pre-explant was 0.04±0.07 logMAR and 0.04±0.11 logMAR post-explant (n=19). Significant differences were observed between pre-implant and post-explant UDVA (p=0.009), and between pre-explant and post-explant UDVA (p=0.02). All patients (100%) had 20/20 or better CDVA pre-implant but decreased to 73.7% post-explant. Sixty percent (12/20) of the patients lost UDVA Snellen acuity lines post-explant. MRSE was −0.31±0.29 D pre-implant and +0.26±0.77 D post-explant (p=0.007) with note of a hyperopic shift. The hyperopic shift in 31.6% (6/19) of patients did not resolve after explantation. Post-explant residual corneal haze occurred in 72.7% (16/22) of patients. CONCLUSION: Although the KAMRA corneal inlay is a removable device, patients may experience residual corneal haze, hyperopic shift, and deficits in UDVA after explantation compared to pre-implantation UDVA. Dove 2022-10-10 /pmc/articles/PMC9553435/ /pubmed/36237487 http://dx.doi.org/10.2147/OPTH.S382544 Text en © 2022 Moshirfar et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Moshirfar, Majid
Lau, Chap-Kay
Chartrand, Nicholas A
Parsons, Mark T
Stapley, Seth
Bundogji, Nour
Ronquillo, Yasmyne C
Linn, Steven H
Hoopes, Phillip C
Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title_full Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title_fullStr Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title_full_unstemmed Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title_short Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis
title_sort explantation of kamra corneal inlay: 10-year occurrence and visual outcome analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553435/
https://www.ncbi.nlm.nih.gov/pubmed/36237487
http://dx.doi.org/10.2147/OPTH.S382544
work_keys_str_mv AT moshirfarmajid explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT lauchapkay explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT chartrandnicholasa explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT parsonsmarkt explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT stapleyseth explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT bundogjinour explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT ronquilloyasmynec explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT linnstevenh explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis
AT hoopesphillipc explantationofkamracornealinlay10yearoccurrenceandvisualoutcomeanalysis